Table 3.
1- and 2-year mortality stratified for assessment parameters and p values
| 1-year mortality | 2-year mortality | |||
|---|---|---|---|---|
| p value | p value | |||
| Age (years) | ||||
| 71–80 | 14.9% | p = 0.000 | 26.4% | p = 0.000 |
| 81–90 | 27.9% | 38.9% | ||
| 91–95 | 39.4% | 55% | ||
| Gender | ||||
| Male | 34.5% | p = 0.015 | 41.8% | p = 0.31 |
| Female | 24.4% | 37.3% | ||
| PMS | ||||
| PMS 7–9 | 13.4% | p = 0.000 | 18.3% | p = 0.000 |
| PMS 4–6 | 23.0% | 35.3% | ||
| PMS 0–3 | 39.7% | 53.4% | ||
| BI | ||||
| BI 70–100 | 9.5% | p = 0.000 | 12.7% | p = 0.000 |
| BI 35–65 | 19.6% | 32.0% | ||
| BI 0–30 | 43.3% | 54.9% | ||
| CCI | ||||
| CCI 0–1 | 19.0% | p = 0.007 | 26.8% | p = 0.000 |
| CCI 2–3 | 26.8% | 39.7% | ||
| CCI ≥ 4 | 33.1% | 46.0% | ||
| Dementia | ||||
| No dementia | 21.0% | p = 0.000 | 31.8% | p = 0.000 |
| Dementia | 37.4% | 51.5% | ||
| Depression by GDS | ||||
| GDS ≤ 5 | 22.0% | p = 0.246 | 31.9% | p = 0.176 |
| GDS > 5 | 27.0% | 38.3% | ||
| Sarcopenia | ||||
| No | 19.6% | p = 0.000 | 29.0% | p = 0.000 |
| Yes | 38.3% | 45.9% | ||
| Frequent falling | ||||
| No | 21.0% | p = 0.065 | 27.2% | p = 0.001 |
| Yes | 28.6% | 42.1% | ||
| LOS | ||||
| < 1 week | 33.3% | p = 0.319 | 42.0% | p = 0.583 |
| 1–2 weeks | 27.3% | 36.1% | ||
| > 2 weeks | 25.1% | 39.3% | ||
| CL | ||||
| No CL | 18.1% | p = 0.000 | 25.8% | p = 0.000 |
| CL 1 | 33.5% | 47.8% | ||
| CL 2 | 29.2% | 40.4% | ||
| CL 3 | 50.0% | 75.0% | ||
| POR | ||||
| PV | 23.2% | p = 0.000 | 32.3% | p = 0.000 |
| AL | 21.1% | 44.7% | ||
| NH | 40.5% | 56.5% | ||